← Latest Filings

B

Bernstein Harold

President, R&D & CMO

Open-market buys

0

$0 total

Open-market sells

24

$8.6M total

Tracking since

Dec 2025

Activity timeline

Open-market sale — $435K

Maze Therapeutics, Inc. · Oct 1, 2026

Open-market sale — $255K

Maze Therapeutics, Inc. · Sep 4, 2026

Open-market trades from the last two years.

Holdings as last reported

144,521 Stock Option (Right to Buy) in MAZE

Held directly · as of 2026-10-01

20,000 Restricted Stock Units in MAZE

Held directly · as of 2026-09-01

Companies touched

Maze Therapeutics, Inc.